Diyong Xu

Insider Reports History

Location
New York, NY
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Diyong Xu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. Director Stock Option (Right to Buy) 53,521 $171,333 $13.42 23 Oct 2025 Direct

Insider Reports Filed by Diyong Xu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QTTB Q32 Bio Inc. 23 Oct 2025 1 $0 4 Director 27 Oct 2025, 21:25
QTTB Q32 Bio Inc. 24 Feb 2025 2 $0 4 Director 26 Feb 2025, 21:59
QTTB Homology Medicines, Inc. 25 Mar 2024 1 $0 4 Director, 10%+ Owner 27 Mar 2024, 17:39
QTTB Homology Medicines, Inc. 25 Mar 2024 0 $0 3 Director, 10%+ Owner 27 Mar 2024, 17:23